The Vox Markets Podcast / Cathal Friel & Jeremy Skillington of Poolbeg Pharma discuss progress on their lead asset POLB 001

View our embed guidelines

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.